131 related articles for article (PubMed ID: 36935025)
21. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract][Full Text] [Related]
22. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in invasive adenocarcinoma of the cervix.
Stolnicu S; Hoang L; Soslow RA
Virchows Arch; 2019 Nov; 475(5):537-549. PubMed ID: 31209635
[TBL] [Abstract][Full Text] [Related]
24. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
[TBL] [Abstract][Full Text] [Related]
26. Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma.
Qiu J; Qu X; Wang Y; Guo C; Lv B; Jiang Q; Su W; Wang L; Hua K
Adv Sci (Weinh); 2023 Apr; 10(10):e2204951. PubMed ID: 36725337
[TBL] [Abstract][Full Text] [Related]
27. Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional Study.
Bulutay P; Haberal N; Özen Ö; Erdem Ö; Zeren EH; Kulac İ; Taskiran Ç; Vatansever D; Ayhan A; Kapucuoğlu N
Int J Gynecol Pathol; 2022 Sep; 41(5):447-458. PubMed ID: 34856570
[TBL] [Abstract][Full Text] [Related]
28. Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study.
Wang Y; Chang RJ; Luo RZ; Yu J; Zhang X; Yang X; Quddus MR; Li L; Yang W; Liu A; Jiang Q; Zhao R; Zhu H; Zhou F; Wang Y; Sheng X; Liu LL; Wen YL; Banet N; Sung CJ; Qi Y; Bi R; Li M; Wang Y; Li J; Lin W; Wang Y; Rivera G; Chen H; Holloway SB; Fadare O; Liu J; Wang J; Lea J; Kong B; Zheng W
Am J Surg Pathol; 2022 May; 46(5):713-724. PubMed ID: 34753864
[TBL] [Abstract][Full Text] [Related]
29. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
[TBL] [Abstract][Full Text] [Related]
30. Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
Neil AJ; Li YY; Hakam A; Nucci MR; Parra-Herran C
Histopathology; 2024 Jan; 84(2):369-380. PubMed ID: 37920148
[TBL] [Abstract][Full Text] [Related]
31. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
[TBL] [Abstract][Full Text] [Related]
32. Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma.
Kim Y; Kim SI; Kim H; Lee M; Kim HS; Kim K; Chung HH; No JH; Kim YB; Kim JW; Park NH; Song YS; Lee C; Suh DH
Gynecol Oncol; 2022 Oct; 167(1):28-36. PubMed ID: 35970602
[TBL] [Abstract][Full Text] [Related]
33. Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 Cases.
Stolnicu S; Karpathiou G; Guerra E; Mateoiu C; Reques A; Garcia A; Bart J; Felix A; Fanni D; Gama J; Hardisson D; Bennett JA; Parra-Herran C; Oliva E; Abu-Rustum N; Soslow RA; Park KJ
Am J Surg Pathol; 2022 Jun; 46(6):765-773. PubMed ID: 34985047
[TBL] [Abstract][Full Text] [Related]
34. Molecular correlates of invasion pattern in HPV-associated endocervical adenocarcinoma: emergence of two distinct risk-stratified tiers.
Sharma AE; Hodgson AJ; Howitt BE; Olkhov-Mitsel E; Djordevic B; Park KJ; Nucci MR; Parra-Herran C
Histopathology; 2023 Jun; 82(7):1067-1078. PubMed ID: 36849702
[TBL] [Abstract][Full Text] [Related]
35. Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Jeong DH
Int J Gynecol Cancer; 2017 Jul; 27(6):1228-1236. PubMed ID: 28604449
[TBL] [Abstract][Full Text] [Related]
36. Testing Algorithms for the Diagnosis of Malignant Glandular Tumors of the Uterine Cervix Histotyped per the International Endocervical Adenocarcinoma Criteria and Classification (IECC) System.
Duggan MA; Duan Q; Pfeiffer RM; Brett MA; Lee S; Abubakar M; Köbel M; Rodriguez M; Sar A
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):91-98. PubMed ID: 34799503
[TBL] [Abstract][Full Text] [Related]
37. [Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].
Zeng SY; Zhong ML; Liang MR; Li L; Jiang W; Yu XH
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):602-6. PubMed ID: 24199926
[TBL] [Abstract][Full Text] [Related]
38. Tumor Spread through Air Spaces Affects the Recurrence and Overall Survival in Patients with Lung Adenocarcinoma >2 to 3 cm.
Dai C; Xie H; Su H; She Y; Zhu E; Fan Z; Zhou F; Ren Y; Xie D; Zheng H; Kadeer X; Chen D; Zhang L; Jiang G; Wu C; Chen C
J Thorac Oncol; 2017 Jul; 12(7):1052-1060. PubMed ID: 28389373
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants.
Byun JM; Cho HJ; Park HY; Kim YN; Lee KB; Sung MS; Jeong CH; Jeong DH
Int J Clin Oncol; 2019 Oct; 24(10):1264-1272. PubMed ID: 31140099
[TBL] [Abstract][Full Text] [Related]
40. Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Pike MC; Soslow RA
Gynecol Oncol; 2018 Jul; 150(1):56-60. PubMed ID: 29859673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]